InfuSystem Holdings, Inc 8-K, filed Feb 7, 2020
InfuSystem Holdings, Inc (INFU)
About this 8-K
InfuSystem Holdings, Inc filed this 8-K on February 7, 2020, reporting on events of February 5, 2020.
Items reported
- Item 5.02: Director or officer change, or executive pay
- Item 9.01: Financial statements and exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 5, 2020
_____________________
InfuSystem Holdings, Inc.
(Exact name of registrant as specified in its charter)
_________________________
|
Delaware |
001-35020 |
20-3341405 |
|
(State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
3851 West Hamlin Road
Rochester Hills, Michigan 48309
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (248) 291-1210
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
___________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities Registered Pursuant to Section 12(b) of the Act:
|
Title of Each Class |
Trading Symbol(s) |
Name of Each Exchange on which Registered |
|
Common Stock, par value $0.0001 per share |
INFU |
NYSE American LLC |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02. Departure of Directors of Certain Officers; Election of Directors: Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Departure of Chief Financial Officer. On February 5, 2020, InfuSystem Holdings, Inc. (the “Company”) and Gregory W. Schulte mutually agreed that Mr. Schulte will cease serving as the Company’s Chief Financial Officer of the Company, effective immediately, and depart from the Company on February 14, 2020.
Appointment of Interim Chief Financial Officer. On February 5, 2020, the Company appointed Wesley W. Winnekins as Interim Chief Financial Officer, effective immediately, to serve during the pendency of the Company’s search for Mr. Schulte’s replacement.
Wesley W. Winnekins, age 58, has served as a financial consultant to numerous private and public companies from March 2017 to the present. From June 2014 to March 2017, Mr. Winnekins served MGC Diagnostics Corporation, a NASDAQ traded company, as its Chief Operating Officer and Chief Financial Officer, and from February 2013 to June 2014, Mr. Winnekins served MGC Diagnostics Corporation as its Executive Vice President, Finance and Corporate Development and Chief Financial Officer.
From February 2011 to October 2012, Mr. Winnekins served as Chief Financial Officer of Snap Fitness, Inc., a multi-national franchisor of 24/7 express fitness clubs. Prior to that, he was employed by Health Fitness Corporation, an NYSE AMEX traded company, from February 2001 to December 2010, serving as Executive Vice President, Finance and Operations from March 2010 to December 2010, as Chief Financial Officer and Treasurer from February 2001 to February 2010. Prior to working at Health Fitness Corporation, Mr. Winnekins served in finance and management capacities for several public and private companies from October 1987 to February 2001. From May 1985 to October 1987, Mr. Winnekins served in the audit practice at Arthur Andersen. Mr. Winnekins received a Bachelor’s in Business Administration with a major in Accounting from Iowa State University and has passed the CPA exam.
In connection with Mr. Winnekins’ appointment as Interim Chief Financial Officer, InfuSystem, Inc. entered into an Independent Contractor Agreement, effective February 5, 2020, with Mr. Winnekins (the “Independent Contractor Agreement”). The Independent Contractor Agreement provides for a minimum term of eight weeks ending on March 31, 2020, but may be terminated by InfuSystem, Inc. at any time and for any reason. Under the Independent Contractor Agreement, Mr. Winnekins will receive $300.00 per hour for his services as Interim Chief Financial Officer. The foregoing description of the Independent Contractor Agreement is only a summary, does not purport to be complete, and is qualified entirely by the full text of the Independent Contractor Agreement, a copy of which is filed as Exhibit 10.1 hereto and incorporated by reference herein.
There are no family relationships between Mr. Winnekins and any director or executive officer of the Company, and Mr. Winnekins is not a party to any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
|
Exhibit No. |
Description |
|
|
10.1 |
||
| 99.1 | Press Release of Infusystem Holdings, Inc. dated February 7, 2020. |
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
INFUSYSTEM HOLDINGS, INC. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By: |
/s/ Richard A. DiIorio |
|
|
|
|
Richard A. DiIorio |
|
|
|
|
President and Chief Executive Officer |
|
Dated: February 7, 2020
Exhibit 10.1
INDEPENDENT CONTRACTOR AGREEMENT
This Independent Contractor Agreement ("Agreement") is made between InfuSystem, Inc., a California corporation ("Corporation") and Wesley W. Winnekins ("Contractor"), an independent contractor.
RECITALS UNDERLYING THIS AGREEMENT
|
RECITAL A. |
Corporation is generally engaged in the business of providing Ambulatory Infusion Pumps and IV Delivery Systems; |
|
RECITAL B. |
Corporation desires to engage Contractor as an independent contractor as Interim Chief Financial Officer. |
|
RECITAL C. |
Contractor and Corporation desire to have their rights and obligations specified herein. |
THEREFORE, in consideration of the mutual covenants contained herein, the parties hereto agree as follows:
Section 1. Scope of Engagement.
A. Corporation retains the independent contractor services of Contractor to provide the Board of Directors, Chief Executive Officer, and Executive Management Team with recommendations regarding Corporate business matters.
B. Contractor shall not make any representations regarding the services of Corporation apart from those which Contractor is specifically authorized to make by Corporation, or enter into any agreements, commitments or contracts on behalf of Corporation apart from those which Contractor is specifically authorized to make by Corporation in writing.
C. In all dealings with outside counsel, outside accountants, customers, suppliers, public officials, regulators, investors and the general public, Contractor must adhere to the highest standards of business behavior, honesty, integrity, fair dealing and ethical conduct and in compliance with all applicable laws, rules and regulations and policies of Corporation and its affiliates. Contractor agrees to refrain from any business practice which may expose Corporation to legal action or liability or adversely affect the reputation or image of Corporation or its good will.
D. Contractor is not an employee of Corporation for any purpose whatsoever, shall not hold himself out to be an employee of Corporation, and shall be solely responsible for payment of all income and self-employment taxes for which Contractor may be liable as a result of compensation paid pursuant to this Agreement. Corporation will provide an annual statement of all compensation paid to Contractor on Form 1099. Any person employed or retained by Contractor is likewise not an employee of Corporation. Contractor has the sole responsibility for paying Contractor’s employees, making deductions and reporting compensation as required by law, and obtaining workers compensation insurance.
Section 2. Term of Agreement.
A. The term of this Agreement shall be effective Wednesday, February 5, 2020 for a minimum of 8 weeks ending on March 31, 2020, unless terminated by Corporation or Contractor at any time for any reason whatsoever, or the mutual written agreement of both parties.
B. This Agreement does not guaranty Contractor any work or specific projects or a minimum number of hours. Corporation retains sole discretion over what work and/or projects, if any, may be offered to Contractor.
C. Upon termination of this Agreement for any reason whatsoever, Contractor shall continue to be obligated to adhere to Sections 4, 5, 6, 7, 8, 9 & 11.
Section 3. Compensation and Directors and Officers Insurance
A. Contractor shall be compensated in accordance with Exhibit A hereto.
Section 4. Non-Disclosure of Confidential Information.
Contractor acknowledges that, in and as a result of Contractor’s performing the duties hereunder, Contractor will be making use of, acquiring, creating and/or adding to confidential and proprietary information of a special and unique nature and value relating to the Corporation (“Corporation” for purposes of Section 4 of this Agreement shall include Corporation and its subsidiaries, affiliates and related parties, including, but not limited to, InfuSystem Holdings, Inc. and First Biomedical, Inc.), the contracts, pricing lists, marketing plans, business records, accounting records, sales reports, billing systems, inventory systems, financing and loan documents, bank records, financial records and statements, tax filings and records, account lists, territory reports, quotation forms, advertising and marketing methods and techniques, systems, methodologies, facts, data, patent and license information of Corporation, the computer systems, computer programs, software, web portal solutions, customer sales portal design, development, and programming of Corporation, the employee payroll information and records, employee and patient medical records, information contained in employee personnel files or other employee files of Corporation, and all other information concerning the business and/or affairs of Corporation (hereinafter "Confidential Information").
|
A. |
As an inducement for Corporation to enter into this Agreement, Contractor agrees that Contractor will not, at any time, either during the term of this Agreement or thereafter, divulge or communicate to any person, firm, corporation or entity whatsoever, directly or indirectly, or use for Contractor’s own benefit or the benefit of others, any Confidential Information which may be in Corporation’s possession or to which Contractor has access. Contractor further acknowledges that all records and all matters affecting or relating to the business and financial operation of Corporation are the property of Corporation and are material and confidential and greatly affect the effective and successful conduct of the business of Corporation and the goodwill of Corporation. Contractor hereby agrees that Contractor shall never divulge, disclose or communicate any such information to any person, firm, corporation or other entity during the term of this Agreement or thereafter, except: |
|
i. |
where necessary to perform responsibilities on behalf of the Corporation, and then in accordance with all limitations and the responsibilities of this position; |
|
ii. |
where necessary to comply with any legal obligation, such as a court order or subpoena, provided Contractor shall first promptly notify the Corporation prior to any such disclosure and permit Corporation to intervene to block such disclosure; |
|
iii. |
where necessary, to Corporation’s attorneys, provided that they shall have first been apprised of the limitations of this Agreement and shall have agreed to comply with and be bound by such limitations; or |
|
iv. |
where Contractor has obtained the express, prior written consent from the Corporation. |
B. Contractor agrees that any books, manuals, Board Materials, Business Plans, Presentations or other written or electronic evidence and/or forms of Confidential Information, including, but not limited to emails, computer files and all other electronic media, shall only be used by Contractor during the term of this Agreement and constitute the property of Corporation. Contractor is only authorized to use these materials while undertaking Contractor’s responsibilities under this Agreement. All of these materials must be returned to Corporation by Contractor upon Contractor’s separation from Corporation for any reason whatsoever.
Section 5. Covenants against Competition.
Contractor acknowledges that Contractor’s duties as herein described are of a special character which have a unique value to Corporation, the loss of which could not be adequately compensated by damages in an action at law. In view of the unique value to Corporation of the Contractor's duties for which Corporation has contracted hereunder, because of the Confidential Information to be retained by or disclosed to Contractor as set forth above and as a material inducement to Corporation to enter into this Agreement, Contractor covenants and agrees that, unless Corporation and its successors and assigns shall cease to engage in business:
A. During the term of this Agreement and for a period of one (1) year thereafter, Contractor shall not, directly or indirectly solicit customers of the Corporation for purposes of selling a product or service provided by Corporation (“Corporation” for purposes of Sections 5(A)-(C) of this Agreement shall include Corporation, its parent company, subsidiaries, affiliates and related parties, including, but not limited to, InfuSystem Holdings, Inc. and First Biomedical, Inc.), or divert the customers of Corporation from doing business with Corporation, and further, shall not induce any individual or entity to refrain from referring customers or work to Corporation. For purposes of this Section 5(A), the customers of Corporation shall include:
|
i. |
any individual, business or governmental entity which purchased goods or services from Corporation at any time prior to the execution of the Agreement or during the term of the Agreement; |
|
ii. |
any individual, business or governmental entity whose name appears on a list of prospective customers maintained by Corporation which list was existing at any time prior to the execution of the Agreement or during the term of the Agreement; |
|
iii. |
any suppliers, distributors, vendors or other entities which provided goods or services to Corporation at any time prior to the execution of the Agreement or during the term of the Agreement; and |
|
iv. |
any non-profit organizations, large customer facilities or referral sources which did any business with, or referred any customers to, Corporation at any time prior to the execution of the Agreement or during the term of the Agreement. |
B. During the term of this Agreement and for a period of one (1) year thereafter, Contractor shall not, directly or indirectly, own, manage, operate, join, control, accept employment with, or participate in the ownership, management, operation or control of, or act as an employee, agent or consultant to, or be connected in any manner with, any business which is competitive with Corporation and its businesses of providing biomedical infusion pumps or Rental, Sales and Service of biomedical pumps and related supplies and services in any states, territories or provinces of the United States, Canada, or any other countries in which Corporation has conducted business at any time prior to the cessation of Contractor’s provision of services to Corporation, for any reason whatsoever.
C. During the term of this Agreement and for a period of three (3) years thereafter, regardless of the reason for the cessation of Contractor provision of services to Corporation, Contractor shall not, directly or indirectly, solicit for employment or employ any employees, agents or independent contractors of Corporation or its assigns, unless previously agreed to in writing by Corporation or its assigns.
Section 6. Contractor's Review of Sections 5 and 6
A. Contractor has carefully read and considered the provisions of Sections 5 and 6 hereof and, having done so, agrees that the restrictions set forth in such Sections are fair and reasonable and are reasonably required for the protection of the interests of Corporation, its officers, directors and employees. Contractor acknowledges that the restrictions set forth in Sections 5 and 6 hereof will not unreasonably restrict or interfere with Contractor’s ability to obtain future employment.
B. It is the belief of the parties that the best protection which can be given to Corporation which does not in any manner infringe on the rights of Contractor to conduct any unrelated business, is to provide for the restrictions described above. In the event any of said restrictions shall be held unenforceable by any court of competent jurisdiction, the parties hereto agree that it is their desire that such court shall substitute a reasonable judicially enforceable limitation in place of any limitation deemed unenforceable and, as so modified, the covenant shall be as fully enforceable as if it had been set forth herein by the parties. In determining this limitation, it is the intent of the parties that the court recognize that the parties hereto desire that this covenant not to compete be imposed and maintained to the greatest extent possible.
C. In the event of a breach of Sections 5 or 6, Corporation, in addition to and not in limitation of any other rights, remedies or damages available to Corporation at law or in equity, shall be entitled to a permanent injunction, in order to prevent or restrain any such breach by Contractor, or by Contractor's partners, agents, representatives, servants, employers, employees and/or any and all persons directly or indirectly acting for or with Contractor.
Section 7. Intellectual Property.
A. Contractor assigns, and agrees to assign, to Corporation all rights, title and interest in and to all creations which are or may become legally protectable or recognized as forms of intellectual property rights, including all works, whether registrable or not, in which copyright, design right or any form of intellectual property rights may subsist, including, but not limited to all innovations, inventions, improvements, marks, grants, designs, processes, methods, formulas, techniques, and computer programs (all referred to as “Intellectual Property"), which Contractor, either solely or jointly, conceives, makes or reduces to practice during the time that this Agreement is in effect, which relate to or touch upon Contractor’s services to Corporation, or any aspect of Corporation’s business, including but not limited to anything related to Confidential Information. All such Intellectual Property shall be the absolute property of Corporation. Contractor shall make and maintain written records of and promptly and fully disclose to Corporation all such Intellectual Property. Any intellectual property, including any registered patents, owned by Contractor prior to the date hereof, or unrelated to the engagement hereunder, shall remain the sole property of Contractor.
B. During and after termination of Contractor’s services under this Agreement, Contractor and his agents and employees shall perform all useful or necessary acts to assist Corporation, as it may elect, to file patent, design, mark and copyright applications in the United States and foreign countries to protect or maintain rights in the Intellectual Property, and also perform all useful or necessary acts to assist Corporation in any related proceedings or litigation as to such Intellectual Property.
Section 8. Public Statements.
Contractor shall not make any public statements or disclosures regarding the Corporation, this Agreement or the termination of same which are not pre-approved in writing by Corporation. Contractor shall further not make any public statement that would libel, slander, disparage, denigrate or criticize Corporation, its parent company, subsidiaries and affiliates or any of their respective past or present officers, directors, employees or agents. Notwithstanding this Section, nothing contained herein shall limit or impair the ability of any party to provide truthful testimony in response to any validly issued subpoena. Nothing in this Agreement prohibits Contractor from reporting possible violations of federal or state law or regulation to any government agency or entity, including the EEOC, DOL, Department of Justice, Securities and Exchange Commission or making other disclosures that are protected under the whistleblower provisions of applicable law.
Section 9. No Assignment.
A. This Agreement is personal to Contractor and Contractor may not assign nor delegate any of the rights or obligations hereunder.
B. Corporation may, without Contractor’s consent, assign this Agreement to any parent, subsidiary or affiliate of Corporation, to any successor in interest to the business of any of Corporation, or to a purchaser of all or substantially all of the assets of Corporation.
Section 10. Partial Invalidity.
If any term of this Agreement is determined by a Court of competent jurisdiction to be unenforceable, the remainder of the provisions, or the application of such term to persons/circumstances other than those to which it is held unenforceable, shall remain in full force and effect. In such event, this Agreement shall be construed as if such unenforceable provisions were omitted.
Section 11. Miscellaneous.
A. This Agreement shall be binding upon and inure to the benefit of the parties hereto, and their respective heirs, devisees, legatees, personal representatives, successors and assigns.
B. Any action or suit against Corporation arising out of this Agreement, including, but not limited to, claims arising under State or Federal civil rights statutes, must be brought within 180 days of the event giving rise to the claims or be forever barred. Contractor expressly waives any limitation periods to the contrary.
C. This Agreement specifically supersedes any and all negotiations, discussions, proposed drafts and previous agreements relating to Contractor's provision of services during the term. Contractor specifically acknowledges that Contractor is not entitled to deferred compensation, dividends or any ownership interest of any kind in Corporation or any related companies or assets not expressly referenced herein and expressly waives any claims as to same.
D. The prevailing party shall have the right to collect from the other party the reasonable attorney fees, costs and expenses incurred in enforcing the Agreement.
E. Any notices desired or required to be given hereunder, shall be in writing and shall be deemed to have been sufficiently given or served for all purposes, if hand-delivered, sent by certified or registered mail, return receipt requested, postage prepaid, or via overnight delivery service, freight prepaid, to Contractor's last known address.
F. This Agreement sets forth the entire understanding of the parties and shall not be changed or terminated orally. The terms of this Agreement can only be changed through a written instrument signed by the CEO or Board Chairman of the Corporation. The waiver by Corporation of a breach of any provision of this Agreement by Contractor shall not operate or be construed as a waiver of any subsequent breach by Contractor.
G. The parties acknowledge that they jointly drafted this Agreement, that no party can be properly referred to as the drafter of same and that none of the language contained herein can be properly construed against either party as the drafter of same.
H. The section headings as herein used are for convenience of reference only and in no way define, limit or describe the scope or intent of any provision of this Agreement.
I. This Agreement shall be governed by and construed and enforced under the laws of the State of Kansas.
J. The parties expressly agree that the Johnson County Circuit Court in the State of Kansas or the United States District Court for the District of Kansas shall have exclusive jurisdiction over any disputes arising out of this Agreement and that venue is only appropriate in such courts.
K. This Agreement shall become effective only upon execution by both parties. The submission of this Agreement for review to Contractor shall not be construed to be a binding offer.
L. This Agreement may be executed simultaneously in two or more counterparts, each of which together shall constitute one and the same instrument and may be delivered via facsimile or email.
| INFUSYSTEM, INC. |
|
CONTRACTOR |
|
|||
| By: | /s/ Jeannine Sheehan | /s/Wesley W. Winnekins | ||||
| Jeannine Sheehan | Wesley W. Winnekins | |||||
| Chief Administrative Officer | ||||||
| DATE: February 5, 2020 | DATE: February 5, 2020 | |||||
|
|
|
|
|
|||
EXHIBIT A
It is agreed that the rate of compensation for this interim assignment will be set at $300.00 per hour for agreed upon services provided. All invoices shall be submitted directly to Jeannine Sheehan via email and will be paid within 15 days of receipt and supporting documentation.
In addition to the agreed upon compensation, if a company issued laptop is needed, the Company can provide one to the Contractor for the duration of the assignment as well as an InfuSystem email address for company-related correspondence.
Key responsibilities:
|
● |
Partnership with the Finance & Accounting organization to complete, approve and sign the annual report and related SEC certifications and filings. |
|
● |
Light participation in and approval of the Company’s annual proxy statement. |
|
● |
Partnership with Internal Audit Manager on matters of significance. |
|
● |
Minimal oversight for Finance & Accounting team (day-to-day direction and oversight will be provided by CEO and CAO). |
Page 10 of 10
Exhibit 99.1

| InfuSystem Holdings, Inc. | |||
| 3851 W. Hamlin Road | |||
| Rochester Hills, MI 48309 | |||
| 248-291-1210 | |||
| CONTACT: | Joe Dorame, Joe Diaz & Robert Blum | ||
| Lytham Partners, LLC | |||
| 602-889-9700 |
InfuSystem Retains Heidrick & Struggles for Nationwide CFO Search; Appoints Interim CFO
ROCHESTER HILLS, MICHIGAN, February 7, 2020—InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national healthcare service provider facilitating outpatient care for durable medical equipment (“DME”) manufacturers and health care providers, announced today that Gregory Schulte, Executive Vice President and Chief Financial Officer of InfuSystem, and the Company have agreed to a mutual separation. Mr. Schulte’s departure is not the result of any disagreement with the Company regarding its operations or accounting policies or practices. The Company has appointed Wesley W. Winnekins as Interim Chief Financial Officer, effective immediately.
The Company has retained Heidrick & Struggles, a premier provider of executive searches, to assist with a nationwide search for a new Chief Financial Officer.
Richard DiIorio, Chief Executive Officer of InfuSystem, said, “We continue to be very pleased with the progress of the business, particularly the improved operational efficiencies achieved in 2019 while delivering significant growth. I look forward to sharing with investors next month our financial results for the fourth quarter and year-end 2019, and our expectations for 2020.”
“I am happy to announce the appointment of Wes Winnekins as Interim Chief Financial Officer to facilitate a seamless transition to the appointment of a permanent Chief Financial Officer. Wes has previously worked with the Company as a financial consultant and has familiarity with our business. Additionally, he has more than 30 years of experience in accounting and finance encompassing medical devices, light manufacturing, financial services, and healthcare services. We plan to file our Form 10-K for the year ended December 31, 2019 within the required reporting period.”
“I want to thank Greg for his contribution to the Company and wish him the best in his future endeavors. Greg assisted us in a time of significant evolution at InfuSystem that has positioned us for long-term financial growth. I am highly confident that Heidrick & Struggles will identify a successor with the right skill set to help us to continue and drive that future growth,” concluded Mr. DiIorio.
About Heidrick & Struggles
Heidrick & Struggles serves the senior-level talent and leadership needs of the world's top organizations as a trusted advisor across executive search, leadership assessment and development, organization and team effectiveness, and culture shaping services. Heidrick & Struggles pioneered the profession of executive search more than 60 years ago. Today, the firm provides integrated leadership solutions to help their clients change the world, one leadership team at a time.® www.heidrick.com
About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. is a leading provider of infusion pumps and related DME support services to hospitals, clinics and other alternate site healthcare providers. Headquartered in Rochester Hills, Michigan, the Company delivers local, field-based customer support and also operates Centers of Excellence in Michigan, Kansas, California, Massachusetts and Ontario, Canada. The Company’s stock is traded on the NYSE American under the symbol INFU.
Forward-Looking Statements
Certain statements contained in this press release that are not historical facts are considered to be forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, such as statements relating to future actions, business plans, objectives and prospects, future operating or financial performance. The words “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “expect,” “strategy,” “future,” “likely,” variations of such words, and other similar expressions, as they relate to the Company, are intended to identify forward-looking statements. Forward-looking statements are subject to factors, risks and uncertainties that could cause actual results to differ materially, including, but not limited to, our dependence on estimates of collectible revenue, potential litigation, changes in third-party reimbursement processes, changes in law and other risk factors disclosed in the Company’s most recent annual report on Form 10-K and, to the extent applicable, quarterly reports on Form 10-Q. All forward-looking statements made in this press release speak only as of the date hereof. We do not undertake any obligation to update any forward-looking statements to reflect future events or circumstances, except as required by law.
Additional information about InfuSystem Holdings, Inc. is available at www.infusystem.com.